Retinal Ganglion Cell Layer Change in Patients Treated With Anti–Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

This publication has 24 references indexed in Scilit:

• Scleral Thinning After Repeated Intravitreal Injections of Antivascular Endothelial Growth Factor Agents in the Same Quadrant
  Investigative Ophthalmology & Visual Science, 2015
• Risk Factors for Geographic Atrophy After Intravitreal Ranibizumab Injections for Retinal Angiomatous Proliferation
  American Journal of Ophthalmology, 2015
• Focal Relationship Between Structure and Function Within the Central 10 Degrees in Glaucoma
  Investigative Ophthalmology & Visual Science, 2014
• Comparative Study of Macular Ganglion Cell–Inner Plexiform Layer and Peripapillary Retinal Nerve Fiber Layer Measurement: Structure–Function Analysis
  Investigative Ophthalmology & Visual Science, 2013
• Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
  Ophthalmology, 2013
• Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support
  Journal of Biomedical Informatics, 2009
• BEVACIZUMAB IS NOT TOXIC TO RETINAL GANGLION CELLS AFTER REPEATED INTRAVITREAL INJECTION
  Retina, 2009
• The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
  Ophthalmology, 2008
• Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic Injury
  The American Journal of Pathology, 2007
• Age-Related Macular Degeneration Is the Leading Cause of Blindness . . .
  JAMA, 2004